Assessment of Myocardial Perfusion in Coronary Artery Disease by Magnetic Resonance: A Comparison With Positron Emission Tomography and Coronary Angiography

By J. Schwitter, Daniel Nanz, S. Kneifel, K. Bertschinger, M. Büchi, P. R. Knüsel, B. Marincek, T. Lüscher, G. Schulthess. Circulation, 2001

722 citations recorded by the source corpus.

Subfields: Materials Chemistry, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/2eebe134c0ae730609d7a4a3bfbef21969211ba0

Citations in the corpus

• Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial (2002, neutral): “All SAE, n (%) 29 (34) 29 (35) 22 (26) 35 (41)”
• MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. (2008, neutral): “MVD—n (%) 20 (44) 32 (65) 22 (47) 20 (48) 20 (44) LM—n (%) 1 (2) 2 (4) 1 (2) 2 ( 5 ) 2 (4) LAD—n (%) 22 (49) 35 (71) 18 (38) 25 (60) 25 (56) LCX—n (%) 17 (38) 24 (49) 20 (43) 18 (43) 12 (27) RCA—n (%) 23 (51) 31 (63) 23 (49) 16 (38) 20 (44)”